CHELSEA FILE: Open Payments
NPI 1306394143 · CANAL WINCHESTER, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,433 in 325 payments from 21 companies in 2025. Trend: 2023 $3,741 · 2024 $7,936 · 2025 $5,433
Food & beverage: $5,048Education: $385
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 22 | $727 |
| ABBVIE INC. | 50 | $725 |
| Incyte Corporation | 42 | $591 |
| UCB, Inc. | 27 | $588 |
| Janssen Biotech, Inc. | 42 | $518 |
| PFIZER INC. | 36 | $500 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 13 | $372 |
| Regeneron Healthcare Solutions, Inc. | 13 | $295 |
| Organon LLC | 18 | $219 |
| Novartis Pharmaceuticals Corporation | 14 | $181 |
Products named: DUPIXENT, OPZELURA, Bimzelx, TREMFYA, RINVOQ, CIBINQO, SKYRIZI, Zoryve.
Industry payments across OH — which companies pay providers there.
